Cargando…
The systemic immune‐inflammation index is associated with an increased risk of incident cancer—A population‐based cohort study
Several studies found that the systemic immune‐inflammation index (SII) is a prognostic factor for mortality in patients with solid tumors. It is unknown whether an increased SII in generally healthy individuals reflects a risk for developing cancer. Our objective was to investigate the association...
Autores principales: | Fest, Jesse, Ruiter, Rikje, Mulder, Marlies, Groot Koerkamp, Bas, Ikram, M. Arfan, Stricker, Bruno H., van Eijck, Casper H.J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6916270/ https://www.ncbi.nlm.nih.gov/pubmed/30924141 http://dx.doi.org/10.1002/ijc.32303 |
Ejemplares similares
-
The neutrophil-to-lymphocyte ratio is associated with mortality in the general population: The Rotterdam Study
por: Fest, Jesse, et al.
Publicado: (2018) -
Reference values for white blood-cell-based inflammatory markers in the Rotterdam Study: a population-based prospective cohort study
por: Fest, Jesse, et al.
Publicado: (2018) -
Trends in Staging, Treatment, and Survival in Colorectal Cancer Between 1990 and 2014 in the Rotterdam Study
por: Lavrijssen, Birgit D. A., et al.
Publicado: (2022) -
Pathology-confirmed versus non pathology-confirmed cancer diagnoses: incidence, participant characteristics, and survival
por: van der Willik, Kimberly D., et al.
Publicado: (2019) -
Ascertainment of cancer in longitudinal research: The concordance between the Rotterdam Study and the Netherlands Cancer Registry
por: van der Willik, Kimberly D., et al.
Publicado: (2019)